Carta Healthcare released survey findings showing near-total agreement among health system IT leaders that AI works best with clinicians in control. In the most decisive result, 81% of respondents rated clinician involvement in the design and deployment of AI as mostly or vitally important, and not one called it unimportant.
We have rounded up some reports and surveys from around the industry that we thought were of interest.
Carta Healthcare, the leader in enterprise clinical data management, released findings from a national survey of U.S. healthcare leaders showing that AI is proving its worth but failing to expand, and that leaders will not trust it at scale without deep clinical expertise. In the survey’s most lopsided result, 92% said deep healthcare domain expertise is critical when evaluating an AI vendor, with half of all respondents assigning it the maximum possible score. Even where AI has delivered measurable value, 71% of organizations are not expanding it at pace.
Artificial intelligence can take on time-consuming data work, helping healthcare providers work faster and reduce costs while keeping clinicians and other experts in control of critical decisions. Cancer registrars show how.
Every hospital treating cancer patients faces a demanding data obligation: turning sprawling patient records into standardized registry information that can support reporting, benchmarking and research. But the specialized workforce that performs that work is small, while the volume and complexity of cancer data continue to grow.
Brent Dover, CEO of Carta Healthcare, sees artificial intelligence as a way to close that capacity gap without removing credentialed cancer registrars from the process.
A Carta Healthcare survey found 77% of IT leaders have seen better outcomes when AI works alongside clinicians rather than on its own.
A market survey of College of Healthcare Information Management Executives (CHIME) technology leaders, released by Carta Healthcare, highlights an industry consensus across health system C-suites: artificial intelligence must operate as a clinician-governed force multiplier rather than an autonomous replacement for human clinical judgment.
Take a hard look at the scene brewing in healthcare IT, and you'll see the usual suspects: AI and clinician oversight. Carta Healthcare, having muddied the waters a bit in their previous release, comes clean with a new survey among health system IT leaders, stamped on August 11, 2026, from San Francisco. What stands out? A staggering 81% of these execs underscore the vital role of clinicians in steering AI—a slap in the face to any notion of sidelining human judgment.
The full survey findings, including the complete breakdown of what slows AI adoption and what builds trust, are available here.
The CEO of Carta Healthcare discusses recent survey results that suggest why successful pilots often stall, why EHR integration has overtaken trust as the leading adoption barrier – and why more clinical leaders are taking ownership of AI strategy.
Only 20% of EHR data is structured. AI can make that data usable, but human expertise remains central.
AI used in healthcare needs strong data to work from, and that data should be coming principally from robust and...
Carta Healthcare, a provider of enterprise clinical data management, announced Lighthouse for Oncology. Health systems can now apply Carta Healthcare’s Hybrid Intelligence approach to cancer registries, one of the most complex and labor-intensive areas of clinical data abstraction.
